"Designing Growth Strategies is in our DNA"

Contraceptives Market Size, Share, Trends & COVID-19 Impact Analysis, By Product (Contraceptive Drugs, Contraceptive Devices, and Others), By Gender (Male & Female) By Distribution Channel (Healthcare Facilities, Pharmacies, and Others), and Regional Forecast, 2020-2027

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI100064

 


To get information on various segments, share your queries with us

  ATTRIBUTE

  DETAILS

Study Period

  2016-2027

Base Year

  2019

Forecast Period

  2020-2027

Historical Period

  2016-2018

Unit

Value (USD billion)

By Product

  • Contraceptive Drugs
    • Oral
    • Injectable
    • Patches
  • Contraceptive Devices
    • Male Contraceptive Devices
    • Female Contraceptive Devices

By Gender

  • Male
  • Female

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Clinics
  • Online Channel
  • Public Channel & NGO
  • Others

By Geography

  • North America
    • By Product
    • By Gender
    • By Distribution Channel
    • By Country
  • Europe
    • By Product
    • By Gender
    • By Distribution Channel
    • By Country
  • Asia Pacific
    • By Product
    • By Gender
    • By Distribution Channel
    • By Country
  • Latin America
    • By Product
    • By Gender
    • By Distribution Channel
    • By Country
  • Middle East & Africa
    • By Product
    • By Gender
    • By Distribution Channel
    • By Country
  • REPORT UPDATE
    IN PROCESS
  • 2019-2032
    (IN PROCESS)
  • 2024
    (IN PROCESS)
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann